These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 14607506)
1. In vitro effects of combined and sequential delivery of two bone growth factors. Raiche AT; Puleo DA Biomaterials; 2004 Feb; 25(4):677-85. PubMed ID: 14607506 [TBL] [Abstract][Full Text] [Related]
2. Cell responses to BMP-2 and IGF-I released with different time-dependent profiles. Raiche AT; Puleo DA J Biomed Mater Res A; 2004 May; 69(2):342-50. PubMed ID: 15058007 [TBL] [Abstract][Full Text] [Related]
3. Enhanced osteoinduction by controlled release of bone morphogenetic protein-2 from biodegradable sponge composed of gelatin and beta-tricalcium phosphate. Takahashi Y; Yamamoto M; Tabata Y Biomaterials; 2005 Aug; 26(23):4856-65. PubMed ID: 15763265 [TBL] [Abstract][Full Text] [Related]
4. Sequential delivery of BMP-2 and IGF-1 using a chitosan gel with gelatin microspheres enhances early osteoblastic differentiation. Kim S; Kang Y; Krueger CA; Sen M; Holcomb JB; Chen D; Wenke JC; Yang Y Acta Biomater; 2012 May; 8(5):1768-77. PubMed ID: 22293583 [TBL] [Abstract][Full Text] [Related]
5. Biodegradable gelatin microparticles as delivery systems for the controlled release of bone morphogenetic protein-2. Patel ZS; Yamamoto M; Ueda H; Tabata Y; Mikos AG Acta Biomater; 2008 Sep; 4(5):1126-38. PubMed ID: 18474452 [TBL] [Abstract][Full Text] [Related]
6. Collagen-chondroitin sulfate-based PLLA-SAIB-coated rhBMP-2 delivery system for bone repair. Keskin DS; Tezcaner A; Korkusuz P; Korkusuz F; Hasirci V Biomaterials; 2005 Jun; 26(18):4023-34. PubMed ID: 15626448 [TBL] [Abstract][Full Text] [Related]
7. Observations on the effect of BMP-2 on rat bone marrow cells cultured on titanium substrates of different roughness. van den Dolder J; de Ruijter AJ; Spauwen PH; Jansen JA Biomaterials; 2003 May; 24(11):1853-60. PubMed ID: 12615475 [TBL] [Abstract][Full Text] [Related]
8. Functionalization of multilayered DNA-coatings with bone morphogenetic protein 2. van den Beucken JJ; Walboomers XF; Boerman OC; Vos MR; Sommerdijk NA; Hayakawa T; Fukushima T; Okahata Y; Nolte RJ; Jansen JA J Control Release; 2006 Jun; 113(1):63-72. PubMed ID: 16687187 [TBL] [Abstract][Full Text] [Related]
9. In vitro cellular responses to bioerodible particles loaded with recombinant human bone morphogenetic protein-2. Puleo DA; Huh WW; Duggirala SS; DeLuca PP J Biomed Mater Res; 1998 Jul; 41(1):104-10. PubMed ID: 9641630 [TBL] [Abstract][Full Text] [Related]
10. Bovine BMP osteoinductive potential enhanced by functionalized dextran-derived hydrogels. Maire M; Chaubet F; Mary P; Blanchat C; Meunier A; Logeart-Avramoglou D Biomaterials; 2005 Aug; 26(24):5085-92. PubMed ID: 15769544 [TBL] [Abstract][Full Text] [Related]
11. Collective review: bioactive implants coated with poly(D,L-lactide) and growth factors IGF-I, TGF-beta1, or BMP-2 for stimulation of fracture healing. Schmidmaier G; Lucke M; Schwabe P; Raschke M; Haas NP; Wildemann B J Long Term Eff Med Implants; 2006; 16(1):61-9. PubMed ID: 16566746 [TBL] [Abstract][Full Text] [Related]
12. Dependence of mesenchymal cell responses on duration of exposure to bone morphogenetic protein-2 in vitro. Puleo DA J Cell Physiol; 1997 Oct; 173(1):93-101. PubMed ID: 9326453 [TBL] [Abstract][Full Text] [Related]
13. [Experimental fusion of the sheep cervical spine. Part II: Effect of growth factors and carrier systems on interbody fusion]. Kandziora F; Scholz M; Pflugmacher R; Krummrey G; Schollmeier G; Schmidmaier G; Schnake KJ; Duda G; Raschke M; Haas NP Chirurg; 2002 Oct; 73(10):1025-38. PubMed ID: 12395162 [TBL] [Abstract][Full Text] [Related]
14. Bone morphogenetic protein-2 decorated silk fibroin films induce osteogenic differentiation of human bone marrow stromal cells. Karageorgiou V; Meinel L; Hofmann S; Malhotra A; Volloch V; Kaplan D J Biomed Mater Res A; 2004 Dec; 71(3):528-37. PubMed ID: 15478212 [TBL] [Abstract][Full Text] [Related]
15. Sustained release of rhBMP-2 from microporous tricalciumphosphate using hydrogels as a carrier. Kissling S; Seidenstuecker M; Pilz IH; Suedkamp NP; Mayr HO; Bernstein A BMC Biotechnol; 2016 May; 16(1):44. PubMed ID: 27206764 [TBL] [Abstract][Full Text] [Related]
16. The fabrication of double-layered chitosan/gelatin/genipin nanosphere coating for sequential and controlled release of therapeutic proteins. Chen R; Cai X; Ma K; Zhou Y; Wang Y; Jiang T Biofabrication; 2017 Jun; 9(2):025028. PubMed ID: 28467316 [TBL] [Abstract][Full Text] [Related]
17. Bone morphogenetic protein-2 and transforming growth factor-beta2 interact to modulate human bone marrow stromal cell proliferation and differentiation. Fromigué O; Marie PJ; Lomri A J Cell Biochem; 1998 Mar; 68(4):411-26. PubMed ID: 9493905 [TBL] [Abstract][Full Text] [Related]
18. In situ controlled release of rhBMP-2 in gelatin-coated 3D porous poly(ε-caprolactone) scaffolds for homogeneous bone tissue formation. Zhang Q; Tan K; Zhang Y; Ye Z; Tan WS; Lang M Biomacromolecules; 2014 Jan; 15(1):84-94. PubMed ID: 24266740 [TBL] [Abstract][Full Text] [Related]
19. Bone morphogenetic protein regulation of early osteoblast genes in human marrow stromal cells is mediated by extracellular signal-regulated kinase and phosphatidylinositol 3-kinase signaling. Osyczka AM; Leboy PS Endocrinology; 2005 Aug; 146(8):3428-37. PubMed ID: 15905316 [TBL] [Abstract][Full Text] [Related]
20. Osteogenic protein-1 and insulin-like growth factor I synergistically stimulate rat osteoblastic cell differentiation and proliferation. Yeh LC; Adamo ML; Olson MS; Lee JC Endocrinology; 1997 Oct; 138(10):4181-90. PubMed ID: 9322928 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]